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The Editors of JEM have been asked to print the following retraction, which was approved by Dr. Larry Pease and by the Mayo Clinic research 
integrity offi   cer who oversaw the investigation:
An investigation by the Mayo Clinic has determined that one of the researchers in Dr. Larry Pease’s laboratory at the Mayo Clinic, Dr. Suresh 
Radhakrishnan, tampered with another investigator’s experiment with the intent to mislead toward the conclusion that the B7-DCXAb reagent 
has cell-activating properties. Using blinded protocols, experiments were done to see if published results based on this reagent could be repli-
cated. Specifi  cally, the repeat experiments examined the activation of dendritic cells, activation of cytotoxic T cells, induction of tumor im-
munity, modulation of allergic responses, breaking tolerance in the RIP-OVA diabetes model, and the reprogramming of Th2 and T regulatory 
cells. In no case did these repeat studies reveal any evidence that the B7-DCXAb reagent had the previously reported activity. The authors of 
this paper therefore wish to retract this paper because they were unable to reproduce key aspects of the studies, and hence the published results 
cannot be considered reliable.
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